pembrolizumab + chemotherapy
Early stage
,
+1 more
state
Adjuvant
,
+1 more
context
Locally advanced
,
+2 more
states
pembrolizumab + carboplatin + cyclophosphamide + paclitaxel + (doxorubicin or epirubicin)
High risk
,
+2 more
states
Adjuvant
,
+1 more
context
samuraciclib + chemotherapy
Locally advanced
,
+1 more
state
trilaciclib + chemotherapy
Locally advanced
,
+1 more
state
immune checkpoint inhibitor + eganelisib + chemotherapy
Locally advanced
,
+2 more
states